Systemic Overexpression of Angiopoietin-2 Promotes Tumor Microvessel Regression and Inhibits Angiogenesis and Tumor Growth
Open Access
- 15 April 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 67 (8), 3835-3844
- https://doi.org/10.1158/0008-5472.can-06-4056
Abstract
Angiopoietin-2 (Ang-2) is a conditional antagonist and agonist for the endothelium-specific Tie-2 receptor. Although endogenous Ang-2 cooperates with vascular endothelial growth factor (VEGF) to protect tumor endothelial cells, the effect on tumor vasculature of high levels of exogenous Ang-2 with different levels of VEGF has not been studied in detail. Here, we report that systemic overexpression of Ang-2 leads to unexpected massive tumor vessel regression within 24 h, even without concomitant inhibition of VEGF. By impairing pericyte coverage of the tumor vasculature, Ang-2 destabilizes the tumor vascular bed while improving perfusion in surviving tumor vessels. Ang-2 overexpression transiently exacerbates tumor hypoxia without affecting ATP levels. Although sustained systemic Ang-2 overexpression does not affect tumor hypoxia and proliferation, it significantly inhibits tumor angiogenesis, promotes tumor apoptosis, and suppresses tumor growth. The similar antitumoral, antiangiogenic efficacy of systemic overexpression of Ang-2, soluble VEGF receptor-1, and the combination of both suggests that concomitant VEGF inhibition is not required for Ang-2–induced tumor vessel regression and growth delay. This study shows the important roles of Ang-2–induced pericyte dropout during tumor vessel regression. It also reveals that elevated Ang-2 levels have profound pleiotropic effects on tumor vessel structure, perfusion, oxygenation, and apoptosis. [Cancer Res 2007;67(8):3835–44]Keywords
Other Versions
This publication has 43 references indexed in Scilit:
- Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancerThe Prostate, 2005
- Increased angiopoietin2 expression is associated with endothelial apoptosis and blood–brain barrier breakdownLaboratory Investigation, 2005
- Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in miceGut, 2005
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiationRole of oxygenation, angiopoietin-1, and matrix metalloproteinasesCancer Cell, 2004
- Angiopoietins in tumours: the angiogenic switchThe Journal of Pathology, 2004
- Endothelial-pericyte interactions in angiogenesisCell and tissue research, 2003
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Angiopoietin-2 Is Implicated in the Regulation of Tumor AngiogenesisThe American Journal of Pathology, 2001
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971